Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Translational Sports Medicine is Scopus-indexed (Q3, CiteScore 2.3), WoS ESCI, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 2573-8488Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Orthopedics and Sports Medicine | 196 / 340 | 42nd | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q3, CiteScore 2.3.
Translational Sports Medicine is Q3 in Orthopedics and Sports Medicine (rank 196 of 340), by CiteScore 2025.
Translational Sports Medicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.3, which places it in quartile Q3 at the 42nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.620, quartile Q2, with an H-index of 18.
The publisher lists an article processing charge of about US$840 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Translational Sports Medicine is published by John Wiley and Sons Ltd. Its ISSN is 2573-8488.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Translational Sports Medicine has an h-index of 24 and a 2-year mean of 2.23 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q3. On 2-year citations it ranks #92 of 331 Scopus journals in Orthopedics and Sports Medicine.
Translational Sports Medicine published 36 papers in 2025; its busiest recent year was 2023 with 147. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2022–2026), authors are most often from United States (13.7%), Denmark (13.3%) and Japan (8.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.